A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines
Vy Phan(University of Massachusetts Amherst), Richard G. Vile(Mayo Clinic), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Fiona Errington‐Mais(St James's University Hospital), Andrew Bateman(McGill University Health Centre), Michael J. Gough(Providence Portland Medical Center), Tim Kottke(Mayo Clinic in Arizona), Alan Melcher(University College Hospital), Annick Brandenburger(Université Libre de Bruxelles), Siew Chiat Cheong(Université Libre de Bruxelles), Bernard Bonnotte(Université de Bourgogne), Steve Emery(AstraZeneca (United Kingdom)), Sharon Altmann(Mayo Clinic)
Cited by 71
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
|Cancer Cell|2018|591
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548